AZD1775
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for AZD1775, covering 2016-06-14 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours [Phase 1]